Estimates Revisions Black Diamond Therapeutics, Inc.
Stocks
BDTX
US09203E1055
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.840 USD | -0.54% |
|
-1.08% | -24.28% |
| 06-29 | Black Diamond Therapeutics, Inc.(NasdaqGS:BDTX) added to Russell 2000 Index | CI |
| 06-29 | Black Diamond Therapeutics, Inc.(NasdaqGS:BDTX) added to Russell 2000 Value Benchmark | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- BDTX Stock
- Consensus Black Diamond Therapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
